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Defects in protein trafficking within the cell body and cilia are thought to underlie the human 
disease Bardet-Biedl syndrome (BBS). In this issue, Nachury et al. (2007) reveal that a 
large complex of proteins implicated in BBS cooperates with Rabin8—the GTP exchange 
factor for the small GTPase Rab8—to promote cilia formation and presumably movement 
of membrane proteins from the cell into the cilium.Cilia are hairlike cellular organelles 
with motile and sensory functions. 
They are assembled and maintained 
by intraflagellar transport (IFT), which 
uses the microtubule-dependent 
motor proteins kinesin-II to mobilize 
ciliary cargo such as receptors and 
dynein to recycle components back 
to the basal body (Inglis et al., 2006). 
Nonmotile (primary) cilia compart-
mentalize receptors and signaling 
machinery, including effectors of 
phototransduction, olfaction, mech-
anosensation, as well as the Wnt, 
Hedgehog, and platelet-derived 
growth factor (PDGF) signaling path-
ways (Inglis et al., 2006). Dysfunc-
tion of primary cilia causes several 
human disorders (ciliopathies), such 
as Bardet-Biedl syndrome (BBS), 
that affect nearly all organs with 
symptoms including obesity, retinal 
degeneration, and polycystic kid-
neys (Blacque and Leroux, 2006). 
In this issue, Nachury et al. (2007) 
report that several proteins known 
to be mutated in BBS are present 
together in a protein complex and 
may regulate movement of mem-
brane proteins into cilia with the help 
of a small GTPase.
Organization of the cilium as an 
extracytoplasmic organelle requires 
vesicular trafficking, a process known 
to be modulated by small GTPases of 
the Rab and Arf families (Takai et al., 
2001). Indeed, defects in trafficking 
to the cilium caused by disruption of 
the small GTPase Rab8 can prevent 
rhodopsin-carrying post-Golgi vesi-
cles from reaching the outer seg-
ment of retinal photoreceptor cells via the connecting cilium, leading 
to retinal degeneration (Moritz et 
al. 2001). This defect is also appar-
ent in mice lacking proteins known 
to be mutated in BBS, which are 
implicated in intracellular trafficking 
in mammalian and zebrafish cells 
and IFT in C. elegans (Blacque and 
Leroux, 2006). Another IFT protein, 
IFT20, localizes to the Golgi complex 
and may assist in the delivery of cili-
ary proteins (Follit et al., 2006). Fur-
thermore, Dwyer et al. (2001) found 
that the C. elegans AP-1 clathrin 
adaptor complex, UNC-101, specifi-
cally sorts some proteins—including 
the odorant receptor ODR-10—from 
the cell body to the ciliary membrane 
at the end of dendrites. Still, our 
understanding of how the trafficking 
of membrane proteins from the Golgi 
to the cilium is regulated remains 
extremely limited.
Nachury et al. (2007) now report a 
functional connection between BBS 
proteins and the Rab8 small GTPase. 
Their finding stems from a decep-
tively simple experiment: a tagged 
BBS protein (BBS4) was precipitated 
from ciliated mammalian cells, and 
the associated proteins were identi-
fied. Stoichiometric amounts of seven 
highly conserved BBS proteins were 
uncovered (BBS1/2/4/5/7/8/9) and 
found to form an ?450 kDa com-
plex, which the authors term the 
“BBSome.” The discovery of a BBS 
complex comprising a subset of the 
12 known BBS proteins is important 
as it helps explain why disruption of 
one or more BBS genes leads to the 
same pleiotropic phenotype. It is also Cell 129,consistent with all C. elegans BBS 
proteins having a common ciliary/IFT 
function and vertebrate BBS proteins 
playing intracellular transport roles 
(Blacque and Leroux, 2006).
Another protein that coprecipitated 
with the BBSome and was found to 
associate specifically with BBS1 
was Rabin8, a GTP exchange factor 
specific for Rab8. Consistent with 
having BBS-associated roles, a frac-
tion of Rabin8 localized to the cen-
trosome/basal body like other BBS 
proteins (Blacque and Leroux, 2006). 
Moreover, depletion of Rabin8 by 
RNA interference resulted in loss of 
BBS4 from centriolar satellites (small 
electron-dense structures adjoin-
ing the centrosome/basal body and 
containing PCM1) and compromised 
cilia formation. Rabin8 was also criti-
cal for allowing Rab8 to enter cilia 
and contribute to ciliogenesis, pre-
sumably by facilitating GTP loading 
of Rab8. Whether Rabin8 depletion 
affected the localization/function of 
its interacting partner BBS1 was not 
investigated but is possible given that 
BBS1 knockdown similarly impaired 
ciliogenesis.
Together, the findings by Nach-
ury et al. (2007) suggest that Rabin8 
helps recruit the BBSome (via BBS1) 
to the centrosome/basal body from 
the neighboring centriolar satellites 
and activates Rab8 to somehow pro-
mote the docking and fusion of vesi-
cles near the ciliary membrane. This 
event likely allows the movement of 
Rab8GTP and probably also BBS pro-
teins into cilia, thereby promoting cil-
iogenesis (Figure 1). Given that BBS4  June 15, 2007 ©2007 Elsevier Inc. 1041
Figure 1. Vesicular Trafficking to the Cilium
Two proteins implicated in Bardet-Biedl syndrome, BBS4 and BBS8, interact with PCM1, a com-
ponent of centriolar satellites. BBS4 and BBS8 also probably associate with other BBS proteins 
of the BBSome before this complex moves to the basal body. After activation by the BBS1-asso-
ciated Rabin8, the GTP-bound Rab8 small GTPase is proposed to facilitate docking and fusion of 
vesicles bearing transmembrane proteins near the ciliary membrane. The BBSome probably first 
docks onto the intraflagellar transport (IFT) machinery present at the transitional fibers and then 
moves into the cilia along with Rab8GTP. During IFT, BBS protein(s) may associate directly or indi-
rectly with BBS3, the ciliary membrane, and potentially also with cargo proteins. BBS6, a basal 
body protein, may facilitate the folding/assembly of BBSome components. The Arl6/BBS3 small 
GTPase could potentially assist any number of vesicular transport events before participating in 
IFT. IFT20 (indicated as 20 in the figure) localizes to the Golgi and may mediate the trafficking of 
other IFT components to the cilium.localizes to cilia and undergoes IFT, 
does the BBSome, like IFT particles, 
associate with vesicles/membranes? 
Nachury and colleagues provided 
evidence for this, showing that BBS4 
ciliary localization is detergent sensi-
tive. Furthermore, a PH-like domain 
was detected in BBS5 and shown to 
bind phosphoinositidyl 3-phosphate, 
a lipid strongly linked to the endo-
somal trafficking pathway (Takai et 
al., 2001).
Rab8 joins several other small 
GTPases implicated in cilia forma-
tion and/or function. These include 
the IFT-associated proteins Arf-like 
6 (Arl6)/BBS3 (Blacque and Leroux, 
2006), Rab-like 5 (IFTA-2; Schafer 
et al., 2006), and Rab-like 4 (IFT27; 1042 Cell 129, June 15, 2007 ©2007 ElsQin et al., 2007). Jenkins et al. (2007) 
recently discovered that mutations 
in human Rab23—a negative regu-
lator of Hedgehog signaling—result 
in Carpenter’s syndrome, which has 
phenotypic overlap with BBS (e.g., 
polydactyly and obesity). Similarly, 
Caspary et al. (2007) showed that 
mice lacking Arl13b, which local-
izes to cilia, display defects in cilia 
structure and Hedgehog signaling. 
Lastly, Arl3-deficient mice develop 
kidney cysts and retinal degenera-
tion, two phenotypes often associ-
ated with ciliopathies (Schrick et al., 
2006).
Based on these findings and the 
study by Nachury et al. (2007), close 
examination of the function of small evier Inc.GTPases in preciliary intracellular 
trafficking and IFT may promote 
our understanding of the mecha-
nisms underlying cilia formation and 
ciliopathies. Some small GTPases 
with ciliary functions can be nar-
rowed down from the over 100 small 
GTPases encoded by the human 
genome (Takai et al., 2001) on the 
basis that most cilia-associated 
proteins localize within the centro-
some/basal body and/or the cilium 
and are absent from organisms 
lacking cilia (e.g., A. thaliana and 
S. cerevisiae). Numerous compara-
tive genomic and proteomic stud-
ies have already made use of these 
criteria to successfully uncover 
many ciliary proteins (Inglis et al., 
2006). However, some important 
ciliogenic proteins may be difficult 
to identify because they have close 
homologs or possess evolutionar-
ily conserved domains also present 
in nonciliated organisms. This is 
true for Rab8 and Rabin8, which 
are related to yeast Sec4p and the 
Sec4p GTP exchange factor, Sec2p, 
respectively. In this case, it will be 
interesting to pinpoint the Rab8-
specific effector(s) in the cilium. 
Other proteins adapted to carry out 
more specialized basal body/ciliary 
functions in higher eukaryotes (e.g., 
BBS6, BBS10-12, and PCM1) may 
be difficult or impossible to identify 
by comparative genomic analyses 
because they are absent from some 
or most ciliated organisms. Finally, 
some proteins may be uncovered 
in directed proteomic analyses of 
basal bodies and cilia, but others 
will be missed if they are scarce or 
function “upstream” of the basal 
body/cilium. Despite these difficul-
ties, the findings of Nachury et al. 
(2007) will promote analysis of a crit-
ical aspect of ciliogenesis—namely 
small GTPase-dependent vesicular 
trafficking between the cell and the 
cilium—our understanding of which 
is still at an early stage.
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